368 related articles for article (PubMed ID: 18049781)
1. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
Thomas KV; Dye C; Schlabach M; Langford KH
J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
[TBL] [Abstract][Full Text] [Related]
2. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
3. Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway.
Plósz BG; Leknes H; Liltved H; Thomas KV
Sci Total Environ; 2010 Mar; 408(8):1915-24. PubMed ID: 20156636
[TBL] [Abstract][Full Text] [Related]
4. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works.
Langford KH; Thomas KV
Environ Int; 2009 Jul; 35(5):766-70. PubMed ID: 19336268
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of steroid estrogen daily concentrations in hospital effluent and connected waste water treatment plant.
Avberšek M; Sömen J; Heath E
J Environ Monit; 2011 Aug; 13(8):2221-6. PubMed ID: 21727965
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
7. Sources of pharmaceutical pollution in the New York City Watershed.
Palmer PM; Wilson LR; O'Keefe P; Sheridan R; King T; Chen CY
Sci Total Environ; 2008 May; 394(1):90-102. PubMed ID: 18280543
[TBL] [Abstract][Full Text] [Related]
8. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
[TBL] [Abstract][Full Text] [Related]
9. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.
Langford K; Thomas KV
J Environ Monit; 2011 Feb; 13(2):416-21. PubMed ID: 21152649
[TBL] [Abstract][Full Text] [Related]
10. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
[TBL] [Abstract][Full Text] [Related]
11. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
Grung M; Källqvist T; Sakshaug S; Skurtveit S; Thomas KV
Ecotoxicol Environ Saf; 2008 Oct; 71(2):328-40. PubMed ID: 18068226
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
Santos JL; Aparicio I; Alonso E
Environ Int; 2007 May; 33(4):596-601. PubMed ID: 17084895
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico.
Brown KD; Kulis J; Thomson B; Chapman TH; Mawhinney DB
Sci Total Environ; 2006 Aug; 366(2-3):772-83. PubMed ID: 16313947
[TBL] [Abstract][Full Text] [Related]
14. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
Carballa M; Omil F; Lema JM; Llompart M; García-Jares C; Rodríguez I; Gómez M; Ternes T
Water Res; 2004 Jul; 38(12):2918-26. PubMed ID: 15223286
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA.
Yu CP; Chu KH
Chemosphere; 2009 Jun; 75(10):1281-6. PubMed ID: 19395062
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
Gracia-Lor E; Sancho JV; Serrano R; Hernández F
Chemosphere; 2012 Apr; 87(5):453-62. PubMed ID: 22221664
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
Strenn B; Clara M; Gans O; Kreuzinger N
Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
[TBL] [Abstract][Full Text] [Related]
18. Populations of antibiotic-resistant coliform bacteria change rapidly in a wastewater effluent dominated stream.
Akiyama T; Savin MC
Sci Total Environ; 2010 Nov; 408(24):6192-201. PubMed ID: 20888028
[TBL] [Abstract][Full Text] [Related]
19. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
20. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
Ort C; Lawrence MG; Reungoat J; Eaglesham G; Carter S; Keller J
Water Res; 2010 Jan; 44(2):605-15. PubMed ID: 19717180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
